Answers are grounded in this paper and cite their sources.
Dual diagnosis with substance use disorders (SUDs) consistently contributes to the premature mortality and increased disability observed in schizophrenia. Large genome-wide association studies are providing the information needed to investigate the genetic architecture of psychiatric disorders. Here, we discuss recent genetic investigations of dual diagnosis (i.e., schizophrenia plus a SUD) and how these findings can inform public health messages.
No takes yet. Share an insight, caveat, or question.
Polimanti et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: